Hospital
Upmc Horizon
Upmc Horizon was paid $8.63M by Medicaid between Jan 2018 and Dec 2024, across 296 billing codes. Its largest line is 99284, emergency room visit (serious) — 29% of everything it billed.
33Billing provider infoUPMC HORIZON
GREENVILLE, PA 16125
GREENVILLE, PA 16125
33aNPI1225048838assigned 08/08/2006
33bProvider typeGeneral Acute Care Hospital
28Total paid$8.63M
24GClaims363,829
24DCodes billed296
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other General Acute Care Hospital providers in Pennsylvania
Rank by total paid#39 of 154
Median peer was paid$2.82M
This provider vs. median3.1×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 160 | $2K | |
| 2019 | 349 | $6K | |
| 2020 | 30,766 | $641K | |
| 2021 | 159,904 | $3.79M | |
| 2022 | 55,753 | $1.36M | |
| 2023 | 65,931 | $1.50M | |
| 2024incomplete | 50,966 | $1.32M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 29% | 22,411 | 21,442 | $2.48M |
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 10% | 11,297 | 10,980 | $880K |
| 99285 | Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life | 6.9% | 3,987 | 3,821 | $596K |
| T1015 | A visit at a community health center or clinic (one all-in rate)Clinic visit/encounter, all-inclusive | 5.0% | 15,053 | 13,502 | $431K |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | 2.5% | 1,478 | 1,438 | $217K |
| 96413 | Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance | 2.3% | 2,120 | 1,166 | $198K |
| 80053 | Comprehensive metabolic panel | 2.2% | 20,594 | 18,373 | $193K |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | 2.2% | 8,467 | 8,045 | $191K |
| 0241U | Neonatal screening for hereditary disorders, genomic sequence analysis panel | 1.9% | 2,110 | 2,083 | $165K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 1.9% | 34,686 | 29,406 | $164K |
| G0378 | Hospital observation service, per hour | 1.6% | 529 | 232 | $138K |
| 80050 | General health panel | 1.4% | 2,564 | 2,493 | $123K |
284 more codes
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | 1.4% | 5,011 | $120K |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | 1.3% | 4,930 | $113K |
| 70450 | Computed tomography, head or brain; without contrast material | 1.1% | 1,786 | $96K |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | 1.1% | 3,072 | $91K |
| 96375 | Therapeutic injection; each additional sequential IV push | <1% | 4,438 | $72K |
| 87480 | <1% | 3,262 | $72K | |
| 87660 | <1% | 3,256 | $71K | |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | <1% | 2,393 | $71K |
| 80061 | Lipid panel | <1% | 4,807 | $64K |
| 88175 | Cytopathology, cervical or vaginal, any reporting system; collected in preservative fluid, automated thin layer | <1% | 2,076 | $62K |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | <1% | 820 | $61K |
| 77067 | Screening mammography, bilateral, including computer-aided detection | <1% | 735 | $59K |
| 73721 | Magnetic resonance imaging, any joint of lower extremity; without contrast material | <1% | 242 | $57K |
| 87624 | Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types | <1% | 1,324 | $48K |
| 76856 | Ultrasound, pelvic (nonobstetric), real time with image documentation; complete | <1% | 1,042 | $47K |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 2,090 | $47K |
| 83735 | <1% | 8,011 | $44K | |
| 71275 | Computed tomographic angiography, chest, with contrast material | <1% | 301 | $44K |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | <1% | 5,376 | $43K |
| 76830 | Ultrasound, transvaginal | <1% | 964 | $39K |
| 72148 | Magnetic resonance imaging, lumbar spine; without contrast material | <1% | 243 | $38K |
| 70553 | Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences | <1% | 176 | $37K |
| 78815 | Positron emission tomography (PET) for limited area imaging | <1% | 52 | $36K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 3,331 | $36K |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | <1% | 528 | $34K |
| 96367 | <1% | 1,637 | $33K | |
| 71045 | Radiologic examination, chest; single view | <1% | 4,983 | $32K |
| 84484 | <1% | 4,262 | $32K | |
| 71046 | Radiologic examination, chest; 2 views | <1% | 2,466 | $30K |
| 87088 | <1% | 4,194 | $30K | |
| 95811 | <1% | 85 | $30K | |
| 93306 | Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete | <1% | 474 | $30K |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | <1% | 751 | $30K |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 3,800 | $28K |
| 70551 | Magnetic resonance imaging, brain; without contrast material | <1% | 122 | $25K |
| 82728 | <1% | 2,112 | $23K | |
| 82607 | <1% | 1,896 | $23K | |
| 83605 | <1% | 3,327 | $21K | |
| 80081 | <1% | 234 | $20K | |
| 71260 | Computed tomography, thorax, diagnostic; with contrast material | <1% | 317 | $20K |
| 86803 | <1% | 971 | $20K | |
| 78452 | Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress | <1% | 108 | $19K |
| 83540 | <1% | 2,301 | $18K | |
| J1756 | Injection, iron sucrose, 1 mg | <1% | 3,242 | $17K |
| 83880 | <1% | 714 | $17K | |
| 93971 | <1% | 292 | $16K | |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 2,440 | $16K |
| 87661 | Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe | <1% | 426 | $16K |
| 77063 | Screening digital breast tomosynthesis, bilateral | <1% | 729 | $16K |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | <1% | 314 | $15K |
| 72141 | <1% | 66 | $15K | |
| 83690 | <1% | 3,717 | $15K | |
| 84702 | <1% | 902 | $15K | |
| 72125 | Computed tomography, cervical spine; without contrast material | <1% | 290 | $14K |
| 81003 | <1% | 5,686 | $14K | |
| 86147 | <1% | 379 | $14K | |
| 81220 | CFTR (cystic fibrosis transmembrane conductance regulator) gene analysis; common variants | <1% | 29 | $14K |
| 99281 | Emergency department visit for the evaluation and management, self-limited or minor | <1% | 473 | $14K |
| 73221 | <1% | 60 | $14K | |
| 84439 | <1% | 1,697 | $13K | |
| 87653 | <1% | 303 | $13K | |
| 87389 | Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies | <1% | 442 | $13K |
| 96366 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour | <1% | 1,056 | $12K |
| 76705 | Ultrasound, abdominal, real time with image documentation; limited | <1% | 381 | $12K |
| 76536 | <1% | 292 | $12K | |
| 82805 | <1% | 404 | $11K | |
| 95886 | <1% | 274 | $11K | |
| J3490 | Unclassified drugs | <1% | 2,866 | $11K |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | <1% | 5,046 | $10K |
| 71250 | <1% | 173 | $10K | |
| 83550 | <1% | 2,158 | $10K | |
| 83970 | <1% | 257 | $10K | |
| 84153 | <1% | 384 | $9K | |
| 87081 | <1% | 1,689 | $9K | |
| 84460 | <1% | 1,397 | $9K | |
| 85730 | <1% | 1,696 | $9K | |
| 84450 | <1% | 1,387 | $9K | |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | <1% | 764 | $9K |
| 96415 | <1% | 300 | $8K | |
| 85610 | <1% | 2,948 | $8K | |
| 73610 | <1% | 520 | $8K | |
| 82565 | <1% | 1,396 | $8K | |
| 76775 | <1% | 182 | $8K | |
| 84481 | <1% | 333 | $8K | |
| 93017 | <1% | 201 | $7K | |
| 87040 | <1% | 615 | $7K | |
| 87077 | <1% | 1,096 | $7K | |
| 73564 | <1% | 356 | $7K | |
| 80076 | <1% | 784 | $7K | |
| 86038 | <1% | 445 | $7K | |
| 96361 | Intravenous infusion, hydration; each additional hour | <1% | 588 | $6K |
| 85652 | <1% | 2,436 | $6K | |
| 86140 | <1% | 2,119 | $6K | |
| 76801 | <1% | 178 | $6K | |
| 72110 | <1% | 310 | $6K | |
| 81329 | <1% | 61 | $6K | |
| 76819 | Fetal biophysical profile; without non-stress testing | <1% | 104 | $6K |
| 82043 | <1% | 730 | $6K | |
| 73030 | <1% | 440 | $6K | |
| 82746 | <1% | 552 | $6K | |
| 73630 | <1% | 569 | $6K | |
| J0185 | Injection, aprepitant, 1 mg | <1% | 214 | $6K |
| 74018 | <1% | 502 | $6K | |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 167 | $6K |
| 76700 | Ultrasound, abdominal, real time with image documentation; complete | <1% | 116 | $5K |
| 87481 | <1% | 524 | $5K | |
| 84403 | <1% | 191 | $5K | |
| 95810 | Polysomnography; sleep staging with 4 or more additional parameters | <1% | 24 | $5K |
| 93970 | <1% | 63 | $5K | |
| 72020 | <1% | 538 | $5K | |
| J2785 | Injection, regadenoson, 0.1 mg | <1% | 195 | $5K |
| 76642 | <1% | 124 | $5K | |
| 86618 | <1% | 212 | $5K | |
| 84100 | <1% | 925 | $5K | |
| 73502 | <1% | 306 | $5K | |
| 81025 | <1% | 1,397 | $5K | |
| 94729 | <1% | 183 | $5K | |
| 72100 | <1% | 256 | $4K | |
| 83001 | <1% | 237 | $4K | |
| 70491 | <1% | 67 | $4K | |
| 76817 | Ultrasound, pregnant uterus, real time with image documentation, transvaginal | <1% | 98 | $4K |
| 73130 | <1% | 383 | $4K | |
| 84550 | <1% | 593 | $4K | |
| 84703 | <1% | 665 | $4K | |
| 85379 | <1% | 483 | $4K | |
| 94726 | <1% | 169 | $4K | |
| 80074 | <1% | 75 | $4K | |
| 74246 | <1% | 100 | $4K | |
| 93880 | <1% | 42 | $3K | |
| 86850 | <1% | 596 | $3K | |
| 82570 | <1% | 479 | $3K | |
| 96523 | <1% | 233 | $3K | |
| J2469 | Injection, palonosetron hcl, 25 mcg | <1% | 900 | $3K |
| J7030 | Infusion, normal saline solution , 1000 cc | <1% | 9,541 | $3K |
| A9577 | Injection, gadobenate dimeglumine (multihance), per ml | <1% | 666 | $3K |
| 84402 | <1% | 115 | $3K | |
| 82784 | <1% | 231 | $3K | |
| 77336 | <1% | 82 | $3K | |
| 82248 | <1% | 419 | $3K | |
| 73110 | <1% | 267 | $3K | |
| 86592 | <1% | 612 | $3K | |
| 82330 | <1% | 454 | $3K | |
| 72050 | <1% | 129 | $3K | |
| 86160 | <1% | 92 | $3K | |
| 96417 | <1% | 62 | $3K | |
| 84132 | <1% | 548 | $3K | |
| 97597 | <1% | 162 | $2K | |
| 93226 | <1% | 74 | $2K | |
| 83615 | <1% | 357 | $2K | |
| 70486 | <1% | 43 | $2K | |
| 81001 | <1% | 872 | $2K | |
| 86200 | <1% | 161 | $2K | |
| 95911 | <1% | 38 | $2K | |
| G0463 | Hospital outpatient clinic visit for assessment and management of a patient | <1% | 439 | $2K |
| 87340 | <1% | 161 | $2K | |
| 73562 | <1% | 147 | $2K | |
| 82950 | <1% | 306 | $2K | |
| 80197 | <1% | 154 | $2K | |
| 83002 | <1% | 122 | $2K | |
| 76641 | <1% | 40 | $2K | |
| 86430 | <1% | 293 | $2K | |
| 82310 | <1% | 318 | $2K | |
| 64493 | <1% | 30 | $2K | |
| 84156 | <1% | 477 | $2K | |
| 86901 | <1% | 658 | $2K | |
| 86900 | <1% | 658 | $2K | |
| 86800 | <1% | 100 | $2K | |
| 82977 | <1% | 200 | $2K | |
| 82962 | <1% | 1,132 | $2K | |
| J1170 | Injection, hydromorphone, up to 4 mg | <1% | 3,414 | $2K |
| 80358 | <1% | 87 | $2K | |
| 82150 | <1% | 457 | $2K | |
| 95909 | <1% | 44 | $2K | |
| 94060 | <1% | 211 | $2K | |
| 82550 | <1% | 283 | $2K | |
| 87522 | Neg quan hep c or qual rna | <1% | 39 | $2K |
| 82105 | <1% | 77 | $2K | |
| J7120 | Ringers lactate infusion, up to 1000 cc | <1% | 4,619 | $2K |
| 87430 | <1% | 266 | $2K | |
| 82375 | <1% | 409 | $2K | |
| 86235 | <1% | 29 | $2K | |
| 76770 | <1% | 33 | $1K | |
| 84520 | <1% | 297 | $1K | |
| 84630 | <1% | 112 | $1K | |
| 76815 | Ultrasound, pregnant uterus, real time with image documentation, limited | <1% | 40 | $1K |
| 36415 | Collection of venous blood by venipuncture | <1% | 4,911 | $1K |
| 86226 | <1% | 80 | $1K | |
| 86003 | <1% | 14 | $1K | |
| 85027 | <1% | 231 | $1K | |
| G0399 | Home sleep test (hst) with type iii portable monitor, unattended; minimum of 4 channels: 2 respiratory movement/airflow, 1 ecg/heart rate and 1 oxygen saturation | <1% | 17 | $1K |
| 93225 | <1% | 86 | $1K | |
| 84146 | <1% | 47 | $1K | |
| 87070 | <1% | 235 | $1K | |
| 82947 | <1% | 446 | $1K | |
| 77066 | Tomosynthesis, mammo | <1% | 14 | $1K |
| 90715 | <1% | 152 | $1K | |
| 72070 | <1% | 70 | $969.59 | |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 4,535 | $966.51 |
| 88342 | <1% | 28 | $961.63 | |
| 86713 | <1% | 46 | $943.97 | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 6,180 | $920.26 |
| 73590 | <1% | 70 | $876.53 | |
| 86376 | <1% | 109 | $841.08 | |
| 84295 | <1% | 441 | $826.80 | |
| 83050 | <1% | 417 | $826.46 | |
| 87205 | <1% | 243 | $821.68 | |
| 73560 | <1% | 70 | $819.71 | |
| 82747 | <1% | 37 | $792.66 | |
| 96411 | <1% | 18 | $792.37 | |
| 77334 | <1% | 17 | $751.30 | |
| 84436 | <1% | 83 | $743.87 | |
| 87186 | <1% | 95 | $734.60 | |
| 86039 | <1% | 52 | $729.75 | |
| 73080 | <1% | 73 | $696.89 | |
| 86696 | <1% | 31 | $687.09 | |
| Q9963 | High osmolar contrast material, 350-399 mg/ml iodine concentration, per ml | <1% | 148 | $654.20 |
| 76816 | Ultrasound, pregnant uterus, real time with image documentation, follow-up | <1% | 14 | $640.65 |
| J0690 | Injection, cefazolin sodium, 500 mg | <1% | 1,143 | $603.02 |
| 86695 | <1% | 31 | $584.95 | |
| 59025 | Fetal non-stress test | <1% | 110 | $582.06 |
| 82435 | <1% | 397 | $560.72 | |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | <1% | 22 | $555.06 |
| J2930 | Injection, methylprednisolone sodium succinate, up to 125 mg | <1% | 466 | $529.10 |
| 99213 | Doctor's office visit, returning patient (routine) | <1% | 13 | $478.10 |
| 73090 | <1% | 43 | $469.23 | |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 1,543 | $450.33 |
| 83655 | <1% | 43 | $449.26 | |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 5,990 | $406.03 |
| 82670 | <1% | 15 | $314.21 | |
| 86812 | <1% | 27 | $309.74 | |
| J2360 | Injection, orphenadrine citrate, up to 60 mg | <1% | 258 | $303.78 |
| 84425 | <1% | 45 | $302.42 | |
| 84165 | <1% | 25 | $299.64 | |
| J0780 | Injection, prochlorperazine, up to 10 mg | <1% | 277 | $278.85 |
| 83921 | <1% | 12 | $250.69 | |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | <1% | 2,116 | $247.66 |
| J3010 | Injection, fentanyl citrate, 0.1 mg | <1% | 1,735 | $244.71 |
| S0020 | Injection, bupivicaine hydrochloride, 30 ml | <1% | 233 | $224.22 |
| 82533 | <1% | 16 | $211.20 | |
| 88142 | <1% | 12 | $211.02 | |
| 80069 | <1% | 21 | $203.66 | |
| G0279 | Diagnostic digital breast tomosynthesis, unilateral or bilateral (list separately in addition to 77065 or 77066) | <1% | 13 | $202.72 |
| 71101 | <1% | 15 | $190.23 | |
| J2765 | Injection, metoclopramide hcl, up to 10 mg | <1% | 1,128 | $189.71 |
| 85018 | <1% | 117 | $183.81 | |
| 85014 | <1% | 106 | $172.36 | |
| 80329 | <1% | 13 | $160.24 | |
| 87329 | <1% | 13 | $143.35 | |
| J3475 | Injection, magnesium sulfate, per 500 mg | <1% | 286 | $127.41 |
| 64494 | <1% | 13 | $114.30 | |
| J1644 | Injection, heparin sodium, per 1000 units | <1% | 201 | $113.40 |
| 86141 | <1% | 12 | $107.53 | |
| J7040 | Infusion, normal saline solution, sterile (500 ml = 1 unit) | <1% | 627 | $103.24 |
| 72170 | <1% | 13 | $89.81 | |
| 87045 | <1% | 16 | $87.60 | |
| J3420 | Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | <1% | 245 | $81.59 |
| 88304 | <1% | 56 | $80.51 | |
| J7050 | Infusion, normal saline solution, 250 cc | <1% | 902 | $79.25 |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | <1% | 1,567 | $73.90 |
| 87046 | <1% | 16 | $65.60 | |
| J1650 | Injection, enoxaparin sodium, 10 mg | <1% | 89 | $65.54 |
| 86308 | <1% | 13 | $65.20 | |
| 85007 | <1% | 15 | $54.94 | |
| J1626 | Injection, granisetron hydrochloride, 100 mcg | <1% | 67 | $39.93 |
| J1040 | Injection, methylprednisolone acetate, 80 mg | <1% | 12 | $37.20 |
| 84155 | <1% | 26 | $32.30 | |
| J2704 | Injection, propofol, 10 mg | <1% | 335 | $30.26 |
| J2060 | Injection, lorazepam, 2 mg | <1% | 157 | $27.74 |
| J2270 | Injection, morphine sulfate, up to 10 mg | <1% | 75 | $18.83 |
| J7512 | Prednisone, immediate release or delayed release, oral, 1 mg | <1% | 671 | $13.69 |
| S0028 | Injection, famotidine, 20 mg | <1% | 21 | $13.44 |
| 94761 | <1% | 29 | $10.07 | |
| J7620 | Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme | 0% | 511 | $0.00 |
| J0131 | Injection, acetaminophen, not otherwise specified,10 mg | 0% | 525 | $0.00 |
| J7613 | Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg | 0% | 87 | $0.00 |
| J7999 | Compounded drug, not otherwise classified | 0% | 376 | $0.00 |
| A9579 | Injection, gadolinium-based magnetic resonance contrast agent, not otherwise specified (nos), per ml | 0% | 135 | $0.00 |
| 96376 | 0% | 18 | $0.00 | |
| J3480 | Injection, potassium chloride, per 2 meq | 0% | 18 | $0.00 |
| J0134 | Injection, acetaminophen (fresenius kabi), not therapeutically equivalent to j0131, 10 mg | 0% | 91 | $0.00 |
| J0665 | Injection, bupivicaine, not otherwise specified, 0.5 mg | 0% | 118 | $0.00 |
| J2919 | Injection, methylprednisolone sodium succinate, 5 mg | 0% | 139 | $0.00 |
| J2916 | Injection, sodium ferric gluconate complex in sucrose injection, 12.5 mg | 0% | 299 | $0.00 |
| J1171 | Injection, hydromorphone, 0.1 mg | 0% | 116 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialFRITZ, BRIAN (CFO)
| Provider | Location | Paid |
|---|---|---|
| Upmc Jameson | New Castle, PA | $6.82M |
| Upmc ST Margaret | Pittsburgh, PA | $5.40M |
| Upmc Jameson | New Castle, PA | $3K |
| Upmc Horizon | Greenville, PA | $1K |
| Upmc ST. Margaret | Pittsburgh, PA | $948.62 |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.